Insulin and hypertensive cardiovascular disease

Current Opinion in Cardiology

Volumn 11, Issue 5, 1996, Pages 483-489

  Kotchen, Theodore A ^a   Kotchen, Jane Morley ^a   O'Shaughnessy, Irene M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

BLOOD CLOTTING; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; GLUCOSE TRANSPORT; HUMAN; HYPERTENSION; INSULIN RESISTANCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOSIS;

EID: 10144220636     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199609000-00006     Document Type: Review

References (80)

1. Wilson PWF, Kannel WB, D'Agostino R: Coronary disease risk factor clusters: prevalance and impact on 16 year incidence of CHD in Framingham offspring [abstract]. Circulation 1996, 93:2.
2. Manolio TA, Savage PJ, Burke GL, Liu L, Wagenknecht S, Jacob DR, Rosenen JM, Donahue RP, Oberman H: Association of fasting insulin with blood pressure and lipids in young adults: the CARDIA study. Arteriosclerosis 1990, 10:430-436.
3. Bonna KH, Thelle DJ: Association between blood pressure and serum lipids in a population: the Tromso study. Circulation 1991, 83:1305-1314.
4. Zanchetti A: Hyperlipidemia in the hypertensive patient Am J Med 1994, 96(suppl 6A):3-8.
5. Taittonen L, Uhari M, Nuutinen M, Turtinen J, Pokka T, Akerblom HK: Insulin and blood pressure among healthy children: cardiovascular risk in young Finns. Am J Hypertens 1996, 9:193-199. This paper demonstrates a correlation between fasting plasma insulin concentrations and blood pressure in over 6000 Finnish children and adolescents.
6. Weidmann P, Bohlen L, de Courten M: Insulin resistance and hyperin sulinemia in hypertension. J Hypertens 1995, 13:S65-S72. This is a review of potential mechanisms by which insulin resistance may cause both hypertension and vascular disease.
7. Mitchell BD, Haffner SM, Hazuda HP, Valdez R, Stern MP: The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol 1992, 136:12-22.
8. National High Blood Pressure Education Program and National Cholesterol Education Program: Working Group Report on Management of Patients with Hypertension and High Blood Cholesterol. Betheseda: National Institutes of Health Publication No. 90-2361, 1990.
9. Laurenzi M, Mancini A, Menotti J, Stamler R, Trevisan M, Zanchetti A: Multiple risk factors in hypertension: results from the Gubbio study. J Hypertens 1990, 8(suppl 20):7-12.
10. Stochmal A, Goldsztajn P, Kawecka-Juszcz K, Kwasniak M, Zdzjencka A, Hartwich J, Lubaszewski W, Dembinska-Kiel A: Relation between insulinaemia and lipoprotein composition in men with primary arterial hypertension with and without hypertriglyceridemia. J Hum Hypertens 1995, 9:113-117.
11. O'Shaughnessy IM, Kotchen TA: Epidemiologic, physiologic, and clinical implications of hypertension and insulin resistance. Curr Opin Cardiol 1993, 8:757-764.
12. Lind L, Berne C, Lithell H: Prevalence of insulin resistance in essential hypertension. J Hypertens 1995, 13:1457-1462. This paper describes approaches for defining insulin resistance and documents its prevalence in a large series of hypertensive patients, based on the euglycemic insulin clamp.
13. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334:374-381. This review makes a case for increased sympathetic nervous system activity contributing to hypertension associated with insulin resistance.
14. Sowers JR, Saleh AA, Sokol RJ: Hyperinsulinemia and insulin resistance are associated with pre-eclampsia in African Americans. Am J Hypertens 1995, 8:1-4.
15. Fuh MMT, Yin CS, Pei D, Sheu WHH, Jeng CY, Chen YDI, Reaven GM: Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had pre-eclampsia during pregnancy. Am J Hypertens 1995, 8:768-771.
16. Falkner B, Hulman S, Kushner H: Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension 1993, 22:18-25.
17. Falkner B, Kushner H, Levison S, Canessa M: Albuminuria in association with insulin and sodium-lithium countertransport in young African Americans with borderline hypertension. Hypertension 1995, 25:1315-1321. In young blacks with borderline hypertension, albuminuria is linked with insulin resistance and with alterations of sodium-lithium countertransport.
18. Haffner SM, Valdez RA, Hazuda HP, Mitchek BD, Morales PA, Stern MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992, 41:715-722.
19. Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991, 34:416-422.
20. Paolisso G, Ferrannini E, Sgambato S, Varricchio M, D'Onofrio F: Hyperinsulinemia in patients with hypercholesterolemia. J Clin Endocrinol Metab 1992, 75:1409-1412.
21. Li R, Arrighi M, Smith L, Brancati F, Heiss G: Dose-response curve of fasting insulin, glucose, and serum lipoproteins: the Atherosclerosis Risk in Communities (ARIC) study [abstract]. Circulation 1996, 93:15.
22. Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM: Insulin resistance and hyperinsulinemia in individuals with small, dense, low density, lipoprotein particles. J Clin Invest 1993, 92:141-146.
23. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
24. Johnson D, Prud'homme D, Despres JP, Nadeau A, Tremblay A, Bouchard C: Relation of abdominal obesity to hyperinsulinemia and high blood pressure in men. Int J Obes 1992, 16:881-890.
25. Muller DC, Elahi D, Pratley RE, Tobin JD, Andres R: An epidemiologic test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab 1993, 76:544-548.
26. Clausen JO, Ibsen H, Diege-Petersen H, Borch-Johnsen K, Pedersen O: The importance of adrenaline, insulin and insulin sensitivity as determinants for blood pressure in young Danes. J Hypertens 1995, 13:499-505.
27. Reaven AM, Laws A: Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 1994, 37:948-952.
28. Eliasson M, Asplund K, Evrin PE, Lindahl B, Lundblad D: Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the northern Sweden MONICA study. Metabolism 1994, 43:1579-1586.
29. van Loon PJP, Kluft C, Radder JK, Blankenstein MA, Meinders AE: The cardiovascular risk factor plasminogen activator type 1 inhibitor is related to insulin resistance. Metabolism 1993, 42:945-949.
30. Folsom AR, Wu KK, Daves CE: Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991, 91:191-205.
31. Norby G, Moan A, Kjeldsen S, Os I: Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women. Am J Hypertens 1995, 8:439-444.
32. Zavaroni I, Mazza S, Fantuzzi M, Dall'aglio E, Bonora E, Delsignore R, Passen M, Reaven GM: Changes in insulin and lipid metabolism in males with asymptomatic hyperuriceamia. J Intern Med 1993, 234:25-30.
33. Vuorinen-Markkola H, Yki-Jarvinen H: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994, 78:25-29.
34. Donnelly R, Connell JMC: Insulin resistance: possible role in the aetiology and clinical course of hypertension. Clin Sci 1992, 83:265-275.
35. Allemann Y, Horber F, Colombo M, Ferrari P, Shaw S, Jaeger P, Weidmann P: Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet 1993, 341:327-331.
36. Ferrannini E, Natal A: Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 1991, 121:1274-1282.
37. Kannel WB, Wilson PWF, Zhang T-J: The epidemiology of impaired glucose tolerance and hypertension. Am Heart J 1991, 121:1268-1273.
38. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y, Heynen G: Altered insulin sensitivity, hyperinsulinemia and dyslipidemia in individuals with a hypertensive parent Am J Med 1991, 91:589-596.
39. Beatty OL, Harper R, Sheridan B, Atkinson AB, Bell PM: Insulin resistance in offspring of hypertensive parents. BMJ 1993, 307:92-96.
40. Peramsetty RB, Grim CE, McGough MF, Cowley AW, Roman RJ, Kotchen TA: Familial hyperlipidemic hypertension in African Americans [abstract]. Circulation 1995, 92(suppl 1):1-153.
41. Williams RR, Hunt SC, Hopkins PN, Stults BM, Wu LL, Hasstedt SJ, Barlow GK, Stephenson SH, Lalouel JM, Kuida H: Familial dyslipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988, 259:3579-3586.
42. Williams RR, Hunt SC, Wu LL, Hopkins PN, Hasstedt SJ, Schumacher MC, Stults BM, Kuida H: Concordant dyslipidemia, hypertension and early coronary disease in Utah families. Klin Wochenschr 1990, 68(suppl XX):52-58.
43. Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR: Concordance for dyslipidemia hypertension in male twins. JAMA 1991, 265:2079-2084.
44. Taylor SI: Molecular mechanisms of insulin resistance: lessons from patients with mutations in the insulin-receptor gene. Diabetes 1992, 41:1473-1490.
45. Fontbonne A: Epidemiologic data on hyperinsulinemia and vascular disease. Diabetes Metab Rev 1993, 9:135-175.
46. Fontbonne A: Why can high insulin levels indicate a risk for coronary heart disease. Diabetologia 1994, 37:953-955.
47. Jarrett RJ: Why is insulin not a risk factor for coronary heart disease. Diabetologia 1994, 37:945-947.
48. Stern MP: The insulin resistance syndrome: the controversy is dead, long live the controversyl Diabetologia 1994, 37:956-958.
49. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais F, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952-957. This prospective study suggests that high fasting plasma insulin concentrations are associated with an increased incidence of ischemic heart disease in nondiabetic men.
50. Nelson RG, Sievers ML, Knowler WC: Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin dependent diabetes. Circulation 1990, 81:987-995.
51. Chaturvedi N, McKeigue PM, Marmot MG: Relationships of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 1994, 37:765-772.
52. Amar J, Chamontin B, Garelli I, Salvador M: Influence of glucose metabolism on nyethemeral blood pressure variability in hypertensives with an elevated waist-hip ratio. Am J Hypertens 1995, 8:426-428.
53. Lind L, Andersson PE, Andren B, Hanni A, Lithell HD: Left ventricular hypertrophy in hypertension is associated with the insulin resistance syndrome. J Hypertens 1995, 13:433-438. Based on multiple regression analysis, left ventricular wall thickness was associated with insulin resistance, as assessed by the euglycemic insulin clamp, in 50 patients with untreated hypertension.
54. Gamble G, MacMahon S, Culpan A, Ciobo C, Whatley G, Sharpe N: Insulin: a determinant of atherosclerosis and left ventricular mass in hypertension [abstract]. Circulation 1996, 93:2.
55. Costa CHRM, Batista MC, Moises VA, Kohlmann NB, Ribeiro AB, Zanella MT: Serum insulin levels, 24-hour blood pressure profile, and left ventricular mass in non-obese hypertensive patients. Hypertension 1995, 26:1085-1088. In nonobese hypertensive patients, insulin resistance was not associated with 24-hour blood pressure profile or left ventricular mass.
56. Sheu WH, Jeng CY, Sheih SM, Fuh MMT, Shen DDC, Chen YDI, Reaven GM: Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens 1992, 5:444-448.
57. Dean JD, Jones CJH, Hutchison SJ: Hyperinsulinaemia and microvascular angina (syndrome X). Lancet 1992, 337:456-457.
58. Fuh MM, Jeng CY, Young MMS, Shen WHH, Chen YDI, Reaven GM: Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with microvascular angina. Metabolism 1993, 42:1090-1092.
59. Zavaroni I, Coruzzi P, Bonini L, Mossini GL, Musiari L, Gasparini P, Fantuzzi M, Reaven GM: Association between salt sensitivity and insulin concentrations in patients with hypertension. Am J Hypertens 1995, 8:855-858.
60. Bigazzi R, Bianchi S, Baldari G, Campese VM: Clustering of cardiovas cular risk factors in salt-sensitive patients with essential hypertension: role of insulin. Am J Hypertens 1996, 9:24-32. In salt-sensitive hypertensive patients, hyperinsulinemia, hyperlipidemia, and microalbuminuria form a cluster with atherogenic potential.
61. Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari G, Natali A, Ferrannini E, Campese VV: Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 1994, 23:681-687.
62. Bianchi S, Bigazzi R, Galvan AQ, Muscelli E, Baldari G, Pecori N, Ciociaro D, Ferrannini E, Natali A: Insulin resistance in microalbuminuric hypertension: sites and mechanisms. Hypertension 1995, 26:789-795. This study suggests that insulin resistance is associated with the intermediate end point of microalbuminuria in essential hypertension.
63. Manttari M, Tiula E, Alikoski T, Manninen V: Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995, 26:670-675. This study presents an important concept, namely that dyslipidemia accelerates the loss of renal function attributed to hypertension.
64. Nutrition Committee of the American Heart Association: Rationale of the heart diet statement of the American Heart Association. Circulation 1993, 88:3008-3029.
65. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993, 153:154-183.
66. Kasiske BL, Ma JZ, Kalil RSN, Louis TA: Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995, 122:133-141. This is a review of the effects of antihypertensive agents on blood lipid levels.
67. Navarro-Cid J, Maeso R, Perez-Vizcaino F, Cachofeiro V, Ruilope LM, Tamargo J, Lahera V: Effects of losartin on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat Hypertension 1995, 26:1074-1078.
68. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
69. American Diabetes Association: Implications of the Diabetes Control and Complications Trial. Diabetes Care 1993, 16:1517-1520.
70. Laakso M: Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 1996, 124(1 pt 2):127-130. This paper presents evidence that poor glycemic control predicts coronary heart disease in patients with non-insulin-dependent diabetes.
71. Abraira C, Johnson N, Colwell J, and the VA CSDM Group: VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): results of the completed feasibility trial [abstract]. Diabetes 1994, 43(suppl 1):59A.
72. Genuth S: Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Ann Intern Med 1996, 124(1 pt 2):104-109.
73. Stern MP: Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med 1996, 124(1 pt 2):110-116. This balanced overview concludes that sufficient data do not exist to indict insulin as an independent cardiovascular disease risk factor and hence recommends that insulin therapy not be withheld in patients with non-insulin-dependent diabetes if it is required to control hyperglycemia.
74. Hermann LS, Schersten B, Bitzen P-O, Kjellstrom T, Lindgarde F, Melander A: Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. Diabetes Care 1994, 17:1100-1109.
75. Grant PJ: The effects of metformin on cardiovascular risk factors. Diabetes Metab Rev 1995, 11:S43-S50.
76. Nagi DK, Yudkin JS: Effects of metformin in insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects: a study of two ethnic groups. Diabetes Care 1993, 16:621-629.
77. Jeppesen J, Zhou M-Y, Chen Y-DI, Reaven GM: Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care 1994, 17:1093-1099.
78. Kotchen TA: Attenuation of hypertension by insulin-sensitizing agents. Hypertension, in press.
79. Nolan JJ, Ludvik B, Beersden P, Joyce M, Olefsky J: Improvement in glucose tolerance and Insulin resistance in obese subjects treated with troglitzone. N Engl J Med 1994, 331:1188-1193.
80. Nestler JE, Beer NA, Jakubowica DA, Colombo C, Beer RM: Effects of insulin reduction with benfluorex on serum DHEA, DHEA sulfate, and blood pressure in middle-aged and elderly men. J Clin Endocrinol Metab 1995, 80:700-706.